Retraction: The Design, Characterizations, and Tumor Angiogenesis Inhibition of a Multi-Epitope Peptibody With bFGF/VEGFA
Main Author: | Frontiers Editorial Office |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2021-01-01
|
Series: | Frontiers in Oncology |
Online Access: | https://www.frontiersin.org/articles/10.3389/fonc.2020.644690/full |
Similar Items
-
The Design, Characterizations, and Tumor Angiogenesis Inhibition of a Multi-Epitope Peptibody With bFGF/VEGFA
by: Ligang Zhang, et al.
Published: (2020-07-01) -
Angiogenesis: bFGF and VEGF in breast carcinoma
by: Vujasinović Tijana, et al.
Published: (2006-01-01) -
Paeonol oxime inhibits bFGF-induced angiogenesis and reduces VEGF levels in fibrosarcoma cells.
by: Hyo-Jeong Lee, et al.
Published: (2010-01-01) -
Retraction: CRISPR/Cas9-Mediated OC-2 Editing Inhibits the Tumor Growth and Angiogenesis of Ovarian Cancer
by: Frontiers Editorial Office
Published: (2021-05-01) -
Peptibody Based on FGFR1-Binding Peptides From the FGF4 Sequence as a Cancer-Targeting Agent
by: Karolina Jendryczko, et al.
Published: (2021-11-01)